Misplaced Pages

Almokalant

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by The chemistds (talk | contribs) at 13:41, 1 October 2011 (added PubchemID, CSID, (Std)InChI & (Std)InChIKey). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 13:41, 1 October 2011 by The chemistds (talk | contribs) (added PubchemID, CSID, (Std)InChI & (Std)InChIKey)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound
Almokalant
Clinical data
ATC code
  • None
Identifiers
IUPAC name
  • 4-(3-{Ethylamino}-2-hydroxypropoxy)benzonitrile
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H28N2O3S
Molar mass352.5 g/mol g·mol
3D model (JSmol)
SMILES
  • O=S(CCC)CCCN(CC)CC(O)COc1ccc(C#N)cc1
InChI
  • InChI=1S/C18H28N2O3S/c1-3-11-24(22)12-5-10-20(4-2)14-17(21)15-23-18-8-6-16(13-19)7-9-18/h6-9,17,21H,3-5,10-12,14-15H2,1-2H3
  • Key:ZMHOBBKJBYLXFR-UHFFFAOYSA-N

Almokalant is drug used to treat arrhythmia. It is a potassium channel blocker. It has been found to have teratogenic effects in rats.

References

  1. Wiesfeld A C; Crijns H J; Bergstrand R H; Almgren O; Hillege H L; Lie K I (1993). "Torsades de pointes with Almokalant, a new class III antiarrhythmic drug". American heart journal. 126 (4): 1008–1011.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. Signs of Almokalant - Teratogenic Agent, wrongdiagnosis.com


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

Categories: